Syringic acid extracted from Herba dendrobii prevents diabetic cataract pathogenesis by inhibiting aldose reductase activity

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Wei, Xiaoyong ^a   Chen, Dan ^a   Yi, Yanchun ^a   Qi, Hui ^a   Gao, Xinxin ^a   Fang, Hua ^a   Gu, Qiong ^b   Wang, Ling ^b   Gu, Lianquan ^b  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; SYRINGIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC CATARACT; DRUG BINDING; DRUG BINDING SITE; DRUG EFFICACY; DRUG EXPOSURE; DRUG ISOLATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; HERBA DENDROBII; HYDROPHOBICITY; IC 50; IN VITRO STUDY; IN VIVO STUDY; LENS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICINAL PLANT; MICROSCOPY; MOLECULAR DOCKING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 84872765562     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/426537     Document Type: Article

References (36)

1. Pollreisz A., Schmidt-Erfurth U., Diabetic cataract-pathogenesis, epidemiology and treatment. Journal of Ophthalmology 2010 2010 5 608751 10.1155/2010/608751
2. Reddy A. B. M., Tammali R., Mishra R., Srivastava S., Srivastava S. K., Ramana K. V., Aldose reductase deficiency protects sugar-induced lens opacification in rats. Chemico-Biological Interactions 2011 191 1-3 346 350 2-s2.0-79957580933 10.1016/j.cbi.2011.02.028
3. Anil Kumar P., Bhanuprakash Reddy G., Focus on Molecules: aldose reductase. Experimental Eye Research 2007 85 6 739 740 2-s2.0-36448941225 10.1016/j.exer.2006.08.002 (Pubitemid 350166360)
4. Kawakubo K., Mori A., Sakamoto K., Nakahara T., Ishii K., GP-1447, an inhibitor of aldose reductase, prevents the progression of diabetic cataract in rats. Biological and Pharmaceutical Bulletin 2012 35 6 866 872
5. Kim J., Kim C.-S., Sohn E., Lee Y. M., Kim J. S., KIOM-79 inhibits aldose reductase activity and cataractogenesis in Zucker diabetic fatty rats. Journal of Pharmacy and Pharmacology 2011 63 10 1301 1308 10.1111/j.2042-7158.2011. 01341.x
6. Hotta N., Akanuma Y., Kawamori R., Matsuoka K., Oka Y., Shichiri M., Toyota T., Nakashima M., Yoshimura I., Sakamoto N., Shigeta Y., Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative aldose reductase inhibitor-diabetes complications trial. Diabetes Care 2006 29 7 1538 1544 2-s2.0-33746456027 10.2337/dc05-2370 (Pubitemid 44127578)
7. + currents and nerve conduction in human diabetics. Neurology 2006 66 10 1545 1549 2-s2.0-33745398891 10.1212/01.wnl.0000216260.39452.bf (Pubitemid 43958552)
8. Patel D. K., Kumar R., Laloo D., Hemalatha S., Evaluation of phytochemical and antioxidant activities of the different fractions of Hybanthus enneaspermus (Linn.) F. Muell. (Violaceae). Asian Pacific Journal of Tropical Medicine 2011 4 5 391 396 2-s2.0-79959438711 10.1016/S1995-7645(11)60110-7
9. Gacche R. N., Dhole N. A., Aldose reductase inhibitory, anti-cataract and antioxidant potential of selected medicinal plants from the Marathwada region, India. Natural Product Research 2011 25 7 760 763 2-s2.0-79953688713 10.1080/14786419.2010.536951
10. Lee J., Jang D. S., Kim N. H., Lee Y. M., Kim J., Kim J. S., Galloyl glucoses from the seeds of Cornus officinalis with inhibitory activity against protein glycation, aldose reductase, and cataractogenesis ex vivo. Biological and Pharmaceutical Bulletin 2011 34 3 443 446 2-s2.0-79952320586 10.1248/bpb.34.443
11. Commission of Chinese Pharmacopoeia, Pharmacopoeia of the People's Republic of China pp. 264-265, 2010 Beijing, China China Medical Science and Technology Press
12. Song J. I., Kang Y. J., Yong H.-Y., Kim Y. C., Moon A., Denbinobin, a phenanthrene from Dendrobium nobile, inhibits invasion and induces apoptosis in SNU-484 human gastric cancer cells. Oncology Reports 2012 27 3 813 818 10.3892/or.2011.1551
13. Yoon M. Y., Hwang J. H., Park J. H., Lee M. R., Kim H. J., Park E., Park H. R., Neuroprotective effects of SG-168 against oxidative stress-induced apoptosis in PC12 cells. Journal of Medicinal Food 2011 14 1-2 120 127 2-s2.0-79952076218 10.1089/jmf.2010.1027
14. Li Y., Li F., Gong Q., Wu Q., Shi J., Inhibitory effects of dendrobium alkaloids on memory impairment induced by lipopolysaccharide in rats. Planta Medica 2011 77 2 117 121 2-s2.0-78651488515 10.1055/s-0030-1250235
15. Hwang J. S., Lee S. A., Hong S. S., Han X. H., Lee C., Kang S. J., Lee D., Kim Y., Hong J. T., Lee M. K., Hwang B. Y., Phenanthrenes from Dendrobium nobile and their inhibition of the LPS-induced production of nitric oxide in macrophage RAW 264.7 cells. Bioorganic and Medicinal Chemistry Letters 2010 20 12 3785 3787 2-s2.0-77954214887 10.1016/j.bmcl.2010.04.054
16. Luo A., He X., Zhou S., Fan Y., He T., Chun Z., In vitro antioxidant activities of a water-soluble polysaccharide derived from Dendrobium nobile Lindl. extracts. International Journal of Biological Macromolecules 2009 45 4 359 363 2-s2.0-70249116006 10.1016/j.ijbiomac.2009.07.008
17. Studies on antioxidant activity of benzyl and phenolic components from Dendrobium nobil. J Chin Pham 2008 43 11 839 842
18. Meissner A., Noack T., Proliferation of human lens epithelial cells (HLE-B3) is inhibited by blocking of voltage-gated calcium channels. Pflugers Archiv European Journal of Physiology 2008 457 1 47 59 2-s2.0-52549096485 10.1007/s00424-008-0514-5
19. Azuma M., Shearer T. R., Matsumoto T., David L. L., Murachi T., Calpain II in two in vivo models of sugar cataract. Experimental Eye Research 1990 51 4 393 401 2-s2.0-0025073704 10.1016/0014-4835(90)90151-J (Pubitemid 20315316)
20. Ganeshpurkar, Bhadoriya S. S., Pardhi P., Jain A. P., Rai G., In vitro prevention of cataract by Oyster Mushroom Pleurotus florida extract on isolated goat eye lens. Indian Journal of Pharmacology 2011 43 667 670
21. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 1976 72 1-2 248 254 2-s2.0-0017184389
22. Sahoo P. K., Behera P., Synthesis and biological evaluation of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors. European Journal of Medicinal Chemistry 2010 45 3 909 914 2-s2.0-76149113225 10.1016/j.ejmech.2009.11.031
23. Halder N., Joshi S., Gupta S. K., Lens aldose reductase inhibiting potential of some indigenous plants. Journal of Ethnopharmacology 2003 86 1 113 116 2-s2.0-0037403130 10.1016/S0378-8741(03)00052-7 (Pubitemid 36398665)
24. Wang Z., Ling B., Zhang R., Suo Y., Liu Y., Yu Z., Liu C., Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase. Journal of Molecular Graphics and Modelling 2009 28 2 162 169 2-s2.0-70349332928 10.1016/j.jmgm.2009.06.003
25. Koukoulitsa C., Bailly F., Pegklidou K., Demopoulos V. J., Cotelle P., Evaluation of aldose reductase inhibition and docking studies of 6′-nitro and 6′6′-dinitrorosmarinic acids. European Journal of Medicinal Chemistry 2010 45 4 1663 1666 2-s2.0-77349109715 10.1016/j.ejmech.2009.12.007
26. Steuber H., Zentgraf M., Gerlach C., Sotriffer C. A., Heine A., Klebe G., Expect the unexpected or caveat for drug designers: multiple structure determinations using aldose reductase crystals treated under varying soaking and co-crystallisation conditions. Journal of Molecular Biology 2006 363 1 174 187 2-s2.0-33748758728 10.1016/j.jmb.2006.08.011 (Pubitemid 44414846)
27. Maccari R., Ciurleo R., Giglio M., Cappiello M., Moschini R., Corso A. D., Mura U., Ottanà R., Identification of new non-carboxylic acid containing inhibitors of aldose reductase. Bioorganic and Medicinal Chemistry 2010 18 11 4049 4055 2-s2.0-77953137883 10.1016/j.bmc.2010.04.016
28. Maccari R., Ottanà R., Ciurleo R., Rakowitz D., Matuszczak B., Laggner C., Langer T., Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives. Bioorganic and Medicinal Chemistry 2008 16 11 5840 5852 2-s2.0-44449137462 10.1016/j.bmc.2008.04.072 (Pubitemid 351758852)
29. Xu J. Y., Wu L. Y., Zheng X. Q., Lu J. L., Wu M. Y., Liang Y. R., Green tea polyphenols attenuating ultraviolet B-induced damage to human retinal pigment epithelial cells in vitro. Investigative Ophthalmology and Visual Science 2010 51 12 6665 6670 2-s2.0-79952166203 10.1167/iovs.10-5698
30. Day C., The rising tide of type 2 diabetes. The British Journal of Diabetes & Vascular Disease 2001 1 1 37 43
31. Kyselova Z., Stefek M., Bauer V., Pharmacological prevention of diabetic cataract. Journal of Diabetes and its Complications 2004 18 2 129 140 2-s2.0-2342443119 10.1016/S1056-8727(03)00009-6 (Pubitemid 38559078)
32. Hashim Z., Zarina S., Osmotic stress induced oxidative damage: possible mechanism of cataract formation in diabetes. Journal of Diabetes and Its Complications 2012 26 4 275 279
33. Mulhern M. L., Madson C. J., Danford A., Ikesugi K., Kador P. F., Shinohara T., The unfolded protein response in lens epithelial cells from galactosemic rat lenses. Investigative Ophthalmology and Visual Science 2006 47 9 3951 3959 2-s2.0-33749129989 10.1167/iovs.06-0193 (Pubitemid 46044312)
34. Kosegarten D. C., Maher T. J., Use of guinea pigs as model to study galactose-induced cataract formation. Journal of Pharmaceutical Sciences 1978 67 10 1478 1479 2-s2.0-0018087157 (Pubitemid 9024550)
35. Suryanarayana P., Krishnaswamy K., Bhanuprakash Reddy G., Effect of curcumin on galactose-induced cataractogenesis in rats. Molecular Vision 2003 9 223 230 2-s2.0-0038748009 (Pubitemid 38097591)
36. Kim Y. S., Kim N. H., Lee Y. M., Kim J. S., Preventive effect of chlorogenic acid on lens opacity and cytotoxicity in human lens epithelial cells. Biological and Pharmaceutical Bulletin 2011 34 6 925 928 2-s2.0-79957982662 10.1248/bpb.34.925